A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin

BACKGROUND: Current use of prescribed or over the counter non-steroidal anti-inflammatory drugs (NSAIDs) for pain and osteoarthritis (OA) have untoward gastrointestinal and cardiovascular related side effects, as a result the need for a safe and effective alternative has become unequivocally crucial...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampalis, John S, Brownell, Lidia Alfaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352039/
https://www.ncbi.nlm.nih.gov/pubmed/22480204
http://dx.doi.org/10.1186/1475-2891-11-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352039/
https://www.ncbi.nlm.nih.gov/pubmed/22480204
http://dx.doi.org/10.1186/1475-2891-11-21

Ejemplares similares